1. Home
  2. SMWB vs PLYX Comparison

SMWB vs PLYX Comparison

Compare SMWB & PLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Similarweb Ltd.

SMWB

Similarweb Ltd.

N/A

Current Price

$2.58

Market Cap

240.7M

Sector

Technology

ML Signal

N/A

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$4.78

Market Cap

114.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SMWB
PLYX
Founded
2007
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
240.7M
114.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SMWB
PLYX
Price
$2.58
$4.78
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$8.13
$10.00
AVG Volume (30 Days)
1.7M
3.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.11
N/A
Revenue Next Year
$11.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$2.20
52 Week High
$10.75
$8.15

Technical Indicators

Market Signals
Indicator
SMWB
PLYX
Relative Strength Index (RSI) 27.07 48.51
Support Level $2.46 $2.44
Resistance Level $7.83 $5.05
Average True Range (ATR) 0.20 0.74
MACD 0.11 0.38
Stochastic Oscillator 23.58 44.49

Price Performance

Historical Comparison
SMWB
PLYX

About SMWB Similarweb Ltd.

Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.

Share on Social Networks: